Sign in

CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275414423
Phone
(650) 822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 4 Grant or award EVP & Chief Financial Officer acquired 12,500 shares (grant or award)
  2. 4 Grant or award EVP & Chief Scientific Officer acquired 12,500 shares (grant or award)
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G Stake Amended Statement of Ownership
  5. SC 13G Stake Amended Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 8-K Event Executive or director change
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 8-K Event Executive or director change · Regulation FD disclosure
  17. 8-K Event Regulation FD disclosure
  18. 8-K Event Other events
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 4 Option exercise President & CEO acquired 100,942 shares (option exercise)

Page 20 of 27 · 524 filings